Dietary carbohydrates and fatty liver disease: de novo lipogenesis

Curr Opin Clin Nutr Metab Care. 2018 Jul;21(4):277-282. doi: 10.1097/MCO.0000000000000469.

Abstract

Purpose of review: To review recent evidence for the role of dietary carbohydrate in de novo lipogenesis (DNL) and nonalcoholic fatty liver disease (NAFLD).

Recent findings: A large body of evidence suggests that increased hepatic DNL is a significant pathway contributing to the development of NAFLD. Dietary carbohydrates, in particular, fructose, have been shown to stimulate DNL and increase liver fat, although it is debated whether this is due to excess energy or fructose per se. Recent dietary intervention studies conducted in energy balance show that high-fructose diets increase DNL and liver fat, whereas fructose restriction decreases DNL and liver fat.

Summary: The association of high-carbohydrate and high-sugar diets with NAFLD may in part be explained by the effect of sugar on increasing hepatic DNL.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Diet*
  • Dietary Carbohydrates / adverse effects*
  • Dietary Sugars / adverse effects
  • Energy Metabolism
  • Fructose / adverse effects*
  • Humans
  • Lipogenesis / drug effects*
  • Liver / drug effects*
  • Liver / metabolism
  • Non-alcoholic Fatty Liver Disease / etiology*
  • Non-alcoholic Fatty Liver Disease / metabolism

Substances

  • Dietary Carbohydrates
  • Dietary Sugars
  • Fructose